FIELD: medicine.
SUBSTANCE: method involves administering etiotropic anti-inflammatory desensitizing and blood-vessel-strengthening preparations. 1.5% sodium deoxyribonucleate (Derinate) is additionally intramuscularly administered every other day in a course of 5 to 10 injections. The 0.25% sodium deoxyribonucleate (Derinate) is administered as single dose in to the nasal cavity and into the eye conjunctiva cavity 6 times a day.
EFFECT: enhanced effectiveness of treatment.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PROGRESSING MYOPIA AND ACCOMMODATION SPASM | 2004 |
|
RU2258514C1 |
METHOD OF PROGNOSIS OF EYE LESION CLINICAL COURSE IN REITER'S SYNDROME | 2007 |
|
RU2331884C1 |
THERAPY AND PROPHYLAXIS METHOD FOR PREVENTING BLEPHAROCONJUNCTIVITIS RECURRENCE RELATED TO DEMODICOSIS | 2006 |
|
RU2321378C1 |
METHOD FOR COMPLEX TREATMENT OF INFECTIOUS ACUTE OPTICAL NEURITIS | 2016 |
|
RU2623870C1 |
AGENT AND THERAPY OF EXUDATIVE OTITIS MEDIA | 2008 |
|
RU2358743C1 |
METHOD FOR DEVELOPING A DEPOT OF MEDICINAL SUBSTANCES IN THE FIELD OF OPHTHALMOLOGY | 2004 |
|
RU2268689C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF BACTERIAL CONJUNCTIVITIS | 2011 |
|
RU2446399C1 |
METHOD FOR TREATING SECONDARY DYSTROPHIA CORNEAE | 2004 |
|
RU2277413C2 |
METHOD OF OPHTHALMOHERPES TREATMENT ASSOCIATED WITH PROLONGED DEPRESSIONS | 2006 |
|
RU2327449C1 |
METHOD FOR TREATING UROGENITAL INFECTIONS | 1999 |
|
RU2160604C1 |
Authors
Dates
2005-08-27—Published
2003-07-22—Filed